心脏MRI与FDG PET对心脏结节病诊断准确性的系统评价与Meta分析
该系统评价与Meta分析纳入33项研究(1997例患者,687例心脏结节病),比较心脏MRI与FDG PET的诊断准确性。心脏MRI敏感度高于FDG PET(95% vs 84%,P=0.002),特异度无差异(85% vs 82%,P=0.85)。FDG PET定量评估较定性评估敏感度更高(93% vs 76%,P=0.01),MRI包含T2成像时敏感度更高(99% vs 88%,P=0.001)。
要点
- 心脏MRI诊断心脏结节病的敏感度高于FDG PET(95% vs 84%),特异度两者相似(85% vs 82%)。
- FDG PET采用定量评估较定性评估敏感度更高(93% vs 76%),MRI包含T2成像时敏感度更高(99% vs 88%)。
- 仅6项研究(303例)在同组患者中直接比较两种检查,多数研究存在偏倚风险。
核心结论
- 心脏MRI诊断心脏结节病的敏感度高于FDG PET,但两者特异度相似。
研究设计与样本
- 系统评价与Meta分析,检索Medline、Ovid Epub、Cochrane Central Register of Controlled Trials、Embase、Emcare和Scopus自建库至2022年1月,纳入33项研究(1997例患者,687例心脏结节病),其中17项评估心脏MRI(1031例),26项评估FDG PET(1363例),6项在同组患者中直接比较(303例);采用双变量随机效应Meta分析,Meta回归评估协变量影响,Quality Assessment Tool for Diagnostic Accuracy Studies-2工具评估偏倚风险;研究方案前瞻性注册于International Prospective Register of Systematic Reviews(Prospero protocol CRD42021214776)。
诊断标准与关键数值
- 心脏MRI诊断心脏结节病敏感度95%,FDG PET敏感度84%(P=0.002);心脏MRI特异度85%,FDG PET特异度82%(P=0.85)。
- 限定于直接比较研究的敏感性分析中,心脏MRI与FDG PET敏感度分别为92%和81%,特异度分别为72%和82%。
- FDG PET定量评估较定性评估敏感度更高(93% vs 76%,P=0.01)。
- MRI包含T2成像时较未包含时敏感度更高(99% vs 88%,P=0.001)。
局限性
- 30项研究存在偏倚风险。
- 直接比较心脏MRI与FDG PET的研究数量少。
- 上述局限性使需要进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background There is limited consensus regarding the relative diagnostic performance of cardiac MRI and fluorodeoxyglucose (FDG) PET for cardiac sarcoidosis. Purpose To perform a systematic review and meta-analysis to compare the diagnostic accuracy of cardiac MRI and FDG PET for cardiac sarcoidosis. Materials and Methods Medline, Ovid Epub, Cochrane Central Register of Controlled Trials, Embase, Emcare, and Scopus were searched from inception until January 2022. Inclusion criteria included studies that evaluated the diagnostic accuracy of cardiac MRI or FDG PET for cardiac sarcoidosis in adults. Data were independently extracted by two investigators. Summary accuracy metrics were obtained by using bivariate random-effects meta-analysis. Meta-regression was used to assess the effect of different covariates. Risk of bias was assessed using the Quality Assessment Tool for Diagnostic Accuracy Studies-2 tool. The study protocol was registered a priori in the International Prospective Register of Systematic Reviews (Prospero protocol CRD42021214776). Results Thirty-three studies were included (1997 patients, 687 with cardiac sarcoidosis); 17 studies evaluated cardiac MRI (1031 patients) and 26 evaluated FDG PET (1363 patients). Six studies directly compared cardiac MRI and PET in the same patients (303 patients). Cardiac MRI had higher sensitivity than FDG PET (95% vs 84%; P = .002), with no difference in specificity (85% vs 82%; P = .85). In a sensitivity analysis restricted to studies with direct comparison, point estimates were similar to those from the overall analysis: cardiac MRI and FDG PET had sensitivities of 92% and 81% and specificities of 72% and 82%, respectively. Covariate analysis demonstrated that sensitivity for FDG PET was highest with quantitative versus qualitative evaluation (93% vs 76%; P = .01), whereas sensitivity for MRI was highest with inclusion of T2 imaging (99% vs 88%; P = .001). Thirty studies were at risk of bias. Conclusion Cardiac MRI had higher sensitivity than fluorodeoxyglucose PET for diagnosis of cardiac sarcoidosis but similar specificity. Limitations, including risk of bias and few studies with direct comparison, necessitate additional study. © RSNA, 2022 Online supplemental material is available for this article.
引用
- Aitken, Chan, Urzua Fresno, et al. Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis. Radiology. 2022. PMID: 35579526. doi:10.1148/radiol.213170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。